Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy.
Mohty M, Fegueux N, Exbrayat C, Lu ZY, Legouffe E, Quittet P, Lopez-Martinez E, Latry P, Avinens O, Hertog C, Klein B, Eliaou JF, Rossi JF. Mohty M, et al. Among authors: quittet p. Bone Marrow Transplant. 2001 Aug;28(4):335-9. doi: 10.1038/sj.bmt.1703134. Bone Marrow Transplant. 2001. PMID: 11571504
Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects.
Rossi JF, Fegueux N, Lu ZY, Legouffe E, Exbrayat C, Bozonnat MC, Navarro R, Lopez E, Quittet P, Daures JP, Rouillé V, Kanouni T, Widjenes J, Klein B. Rossi JF, et al. Among authors: quittet p. Bone Marrow Transplant. 2005 Nov;36(9):771-9. doi: 10.1038/sj.bmt.1705138. Bone Marrow Transplant. 2005. PMID: 16113665 Free PMC article. Clinical Trial.
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma.
Mahtouk K, Cremer FW, Rème T, Jourdan M, Baudard M, Moreaux J, Requirand G, Fiol G, De Vos J, Moos M, Quittet P, Goldschmidt H, Rossi JF, Hose D, Klein B. Mahtouk K, et al. Among authors: quittet p. Oncogene. 2006 Nov 16;25(54):7180-91. doi: 10.1038/sj.onc.1209699. Epub 2006 May 29. Oncogene. 2006. PMID: 16732320 Free PMC article.
Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.
Quittet P, Ceballos P, Lopez E, Lu ZY, Latry P, Becht C, Legouffe E, Fegueux N, Exbrayat C, Pouessel D, Rouillé V, Daures JP, Klein B, Rossi JF. Quittet P, et al. Bone Marrow Transplant. 2006 Aug;38(4):275-84. doi: 10.1038/sj.bmt.1705441. Bone Marrow Transplant. 2006. PMID: 16883311 Free PMC article. Clinical Trial.
Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.
Bret C, Hose D, Reme T, Sprynski AC, Mahtouk K, Schved JF, Quittet P, Rossi JF, Goldschmidt H, Klein B. Bret C, et al. Among authors: quittet p. Br J Haematol. 2009 May;145(3):350-68. doi: 10.1111/j.1365-2141.2009.07633.x. Epub 2009 Mar 2. Br J Haematol. 2009. PMID: 19298595 Free PMC article.
Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.
Condomines M, Veyrune JL, Larroque M, Quittet P, Latry P, Lugagne C, Hertogh C, Kanouni T, Rossi JF, Klein B. Condomines M, et al. Among authors: quittet p. J Immunol. 2010 Jan 15;184(2):1079-84. doi: 10.4049/jimmunol.0804159. Epub 2009 Dec 4. J Immunol. 2010. PMID: 19966210 Free PMC article.
64 results